“Nanoparticles for bio-imaging” Patent Landscape 2010

• Publication date: September 2010

In the current development of new imaging technologies, new contrast agents or tracers are necessary to improve visualization. In this contest, nanoparticles appear to be interesting candidates that have high potential because they can combine multiple properties. Today, only 3 imaging nanoparticles has been approved for commercialization and biomedical diagnostic use. These have been developed by Amag Pharmaceuticals (treated separately in this ...

In the current development of new imaging technologies, new contrast agents or tracers are necessary to improve visualization. In this contest, nanoparticles appear to be interesting candidates that have high potential because they can combine multiple properties. Today, only 3 imaging nanoparticles has been approved for commercialization and biomedical diagnostic use. These have been developed by Amag Pharmaceuticals (treated separately in this study) and Bayer. This segment of the market stays clearly to conquer.
This interest results in a very high research and patenting activity in the last years. Mainly institutional applicants positioned themselves specifically on the sector, while only important industrial structures of the imaging field build up their portfolio notably in US and Europe. Asian applicants are noticeably emerging.

The present report analyses the patent environment and notably highlights the different types of nanoparticles (magnetic, quantum dot, …) than have been developed and their potential applications in bio-imaging. IP strategies of the different players seem to show a trend to claim nanoparticles combining multiple properties and so on covering a large range of applications. Is this situation blocking for future filings?
o In a sector where more than 800 patents and patent applications have been filed, this « IP Overview – Nanoparticles for bio-imaging » provides you with a comprehensive panorama of the intellectual property landscape and helps you:
o Position your company’s R&D and IP Portfolio
o Identify key inventors and key players involved in the development of specific nanoparticles
o Understand the collaboration networks and theirs dynamics

Please note that a three months access to the full patent database is also included

Biotechnology Industry

Table of contents

Brief outline of the technology
Brief outline of the market
Patent Query Evolution of patent filings(1989?2008)
Map and evolution of priority filings
Map and evolution of extensions
Industrial & institutional filings over time
Evolution of the number of applicants

Evolution and location of patent filings
Generalities
Main applicants on the entire period(1989?2008)
Main applicants/ affiliates
Part of the portfolio hold by the 10 first applicants
Breakdown of filings of the main institutional / industrial applicants over time
Main applicants in the last 5 years(2003?2008)
Main co?filings between applicants

Analysis of patent applicants
List of the main inventors
Main research teams
Emerging inventors

Analysis of inventors
Breakdown of the portfolio
1/Imaging techniques Evolution of filings
Positioning of institutional applicants, industrial applicants and inventors
2/Properties of NP
Evolution of filings
Positioning of institutional applicants, industrial applicants and inventors
Focus on biodegradable NP
2.1/Types of magnetic NP
Evolution of filings
Positioning of institutional applicants, industrial applicants and inventors
2.2/Types of luminescent NP
Evolution of filings
Positioning of institutional applicants, industrial applicants and inventors
3/Specific Components of the NP Evolution of filings
Positioning of institutional applicants, industrial applicants and inventors
4/Specific targets of NP
Evolution of filings
Positioning of institutional applicants, industrial applicants and inventors
List of the most cited patents and patent applications

Topics of patent filings
Conclusion
Appendices